20100204
 Earnings: Glaxo to Stop Research on New Antidepressants as Its Shifts Focus   By Whalen, Jeanne, The Wall Street Journal,  Feb 5, 2010  Mr. Witty would say only that these related to "quite a number of cases," declining to add whether they were tied to a federal investigation of the company's drug-marketing practices in the U.S. Mr. Witty said Glaxo aims to invest even more of its research funds in experimental drugs discovered by outside academic groups and biotech companies, which he said would improve the company's return on investment.\n   
